Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Glycyrrhizic acid and licorice extract can significantly reduce unwanted hair growth.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

Cetuximab can cause eyelash growth, which is rare but manageable.

The committee decided not to approve the drug due to low effectiveness and high risks.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Xtressé™ gummies are safe and may help improve hair in women with non-scarring hair loss.

Prostaglandin helps regenerate hair follicles after radiation damage.

Gefitinib can cause hair and eyebrow darkening.

The gelatin/β-TCP scaffold with nanoparticles improves wound healing and skin regeneration.

G-CSF effectively treated a teenager's cyclic neutropenia and reduced her symptoms without adverse effects.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

EGF signaling affects gene expression in skin cells, influencing hair growth and potentially cancer.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Ultrasound-activated gel with stem cell vesicles improves skin healing and regeneration.

Ultrasound and GelMA hydrogel with stem cell vesicles improve skin healing and regeneration.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Recent legal rulings favored Genentech, Teva, and upheld guidelines for patent term extensions.